Bluejay Therapeutics

Developer of therapeutics for the treatment of infectious diseases

placeSan Francisco, California, United States calendar_todayFounded 2019 groups3 employees language bluejaytx.com

Registered entities

Social engagement

Social engagement: 4.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include Arkin Holdings, Frazier Life Sciences.

Investor typeCountShare
Venture capital853%
Private equity213%
Other / undisclosed533%

Recent activity

19 Nov 2025
Event
Scaling up hepatitis delta testing: Breaking barriers, seizing opportunities
12 Nov 2025
Event
The World Hepatitis Alliance webinar on scaling up hepatitis delta testing
7 Nov 2025
Event
The Liver Meeting
Coming soon